Literature DB >> 7740800

Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.

M Nishiyama1, I Takashima, T Tanaka, K Yoshida, T Toge, N Nagata, S Iwamori, Y Tamura.   

Abstract

At the time of laparotomy, peritoneal washings were collected from 155 gastric cancer patients and the levels of carcinoembryonic antigen (CEA) determined. The CEA levels in peritoneal washings were statistically independent of those in sera and could more reliably predict the presence of peritoneal metastasis than a cytologic study. Peritoneal recurrence was seen in 14 of 118 patients after curative operation. Of the 14 patients, 10 (71%) had elevated levels of CEA (100 ng/g protein) at surgery. Of these 10 cases, 2 of the tumors were classified as stage IB and 4 had no serosal invasion. Only one patient with peritoneal metastasis and a low CEA level was free from relapse more than 1 year after operation. Kaplan-Meier's analysis showed that a high CEA level in peritoneal washings was a predictor of poor prognosis in patients who underwent either curative or noncurative resection. A proportional hazards regression analysis showed that a high CEA level in peritoneal washings was statistically significant in terms of predicting a shorter interval until peritoneal recurrence (p = 0.0002) and for survival (p = 0.0001). The CEA level in peritoneal washings is therefore of value as an indicator of peritoneal recurrence and prognosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740800     DOI: 10.1007/BF00316997

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  11 in total

1.  Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.

Authors:  H Imanaga; H Nakazato
Journal:  World J Surg       Date:  1977-03       Impact factor: 3.352

2.  Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses.

Authors:  H Baba; D Korenaga; T Okamura; A Saito; K Sugimachi
Journal:  Arch Surg       Date:  1989-09

Review 3.  A review: intraperitoneal cisplatin in the management of patients with ovarian cancer.

Authors:  E F McClay; S B Howell
Journal:  Gynecol Oncol       Date:  1990-01       Impact factor: 5.482

4.  'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.

Authors:  R Abe; T Akiyoshi; T Baba
Journal:  Oncology       Date:  1990       Impact factor: 2.935

5.  Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer.

Authors:  T Asao; T Fukuda; S Yazawa; Y Nagamachi
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

Review 6.  Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials.

Authors:  T Nakajima
Journal:  Jpn J Clin Oncol       Date:  1990-03       Impact factor: 3.019

7.  Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma.

Authors:  T Wobbes; C M Thomas; M F Segers; F M Nagengast
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

8.  Correlation of DNA ploidy and proliferative activity in human gastric cancer.

Authors:  Y Yonemura; K Sugiyama; T Fujimura; X De Aretxabala; T Kamata; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

9.  Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

Authors:  J D Roder; K Böttcher; J R Siewert; R Busch; P Hermanek; H J Meyer
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

10.  Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.

Authors:  J P Kim; O J Kwon; S T Oh; H K Yang
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

View more
  18 in total

1.  Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

Authors:  T Suzuki; T Ochiai; H Hayashi; K Nakajima; A Yasumoto; E Hishikawa; H Shimada; F Horiuchi; S Ohki; K Isono
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma.

Authors:  Manabu Yamamoto; Keiji Yoshinaga; Ayumi Matsuyama; Shinichi Tsutsui; Teruyoshi Ishida
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-09       Impact factor: 4.553

3.  Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.

Authors:  Gun Ick Hwang; Chang Hak Yoo; Byung Ho Sohn; Jun Ho Shin; Yong Lai Park; Heung Dai Kim; Yong Shin Kim; Won Kon Han; Won Kil Pae
Journal:  Cancer Res Treat       Date:  2004-06-30       Impact factor: 4.679

4.  Experimental radioimmunoguided surgery for peritoneal metastases of gastric cancer using anticarcinoembryonic antigen-specific T84.66 F(ab')2.

Authors:  Jin C Kim; Hyun K Hong; Kang H Lee; In H Ka; Seon A Roh; Kum H Koo; Hee C Kim; Seong T Oh; Seong J Oh; Jung S Kim; Kun C Park
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-11       Impact factor: 4.553

5.  Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer.

Authors:  Bahadir Cetin; Can Atalay; Sabahattin Aslan; Bahattin Babacan; Celal Hatipoğlu; Melih Akinci; Abdullah Cetin
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  Prognostic significance of peritoneal washing cytology in Thai patients with gastric adenocarcinoma undergoing curative D2 gastrectomy.

Authors:  Chakrapan Euanorasetr; Panuwat Lertsithichai
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

7.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

8.  Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.

Authors:  Kaitlyn J Kelly; Joyce Wong; Rebecca Gladdy; Kimberly Moore-Dalal; Yanghee Woo; Mithat Gonen; Murray Brennan; Peter Allen; Yuman Fong; Daniel Coit
Journal:  Ann Surg Oncol       Date:  2009-09-18       Impact factor: 5.344

Review 9.  Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives.

Authors:  Yoshiyuki Fujiwara; Yuichiro Doki; Hirokazu Taniguchi; Itsuro Sohma; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Morito Monden
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

Review 10.  Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis.

Authors:  Y Xiao; J Zhang; X He; J Ji; G Wang
Journal:  Ir J Med Sci       Date:  2013-12-31       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.